MX2007004427A - Intermedio de rosuvastatina cristalina. - Google Patents
Intermedio de rosuvastatina cristalina.Info
- Publication number
- MX2007004427A MX2007004427A MX2007004427A MX2007004427A MX2007004427A MX 2007004427 A MX2007004427 A MX 2007004427A MX 2007004427 A MX2007004427 A MX 2007004427A MX 2007004427 A MX2007004427 A MX 2007004427A MX 2007004427 A MX2007004427 A MX 2007004427A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline rosuvastatin
- rosuvastatin intermediate
- crystalline
- processes
- preparation
- Prior art date
Links
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title abstract 2
- 229960000672 rosuvastatin Drugs 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Se proporciona un intermedio de rosuvastatina cristalina y procesos para la preparacion del mismo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70892005P | 2005-08-16 | 2005-08-16 | |
US71093005P | 2005-08-23 | 2005-08-23 | |
PCT/US2006/032539 WO2007022488A2 (en) | 2005-08-16 | 2006-08-16 | Crystalline rosuvastatin intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007004427A true MX2007004427A (es) | 2007-06-14 |
Family
ID=37671343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007004427A MX2007004427A (es) | 2005-08-16 | 2006-08-16 | Intermedio de rosuvastatina cristalina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US7868169B2 (es) |
EP (1) | EP1805148A2 (es) |
JP (1) | JP2008515931A (es) |
KR (1) | KR20070062996A (es) |
BR (1) | BRPI0605917A2 (es) |
CA (1) | CA2619576C (es) |
IL (1) | IL186221A (es) |
MX (1) | MX2007004427A (es) |
TW (1) | TW200800917A (es) |
WO (1) | WO2007022488A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070167625A1 (en) * | 2005-02-22 | 2007-07-19 | Anna Balanov | Preparation of rosuvastatin |
WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
US8653265B2 (en) | 2008-05-27 | 2014-02-18 | Changzhou Pharmaceutical Factory | Preparation method of rosuvastatin calcium and its intermediates |
IT1397912B1 (it) * | 2010-01-28 | 2013-02-04 | Chemi Spa | Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato. |
CA2832343A1 (en) | 2011-04-18 | 2012-10-26 | Basf Se | Multicomponent crystalline system of rosuvastatin calcium salt and vanillin |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
US4739073A (en) | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
NO177005C (no) | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
US5177080A (en) | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
ATE161262T1 (de) | 1991-06-19 | 1998-01-15 | Shionogi & Co | Optisch aktives zwischenprodukt und dessen herstellung |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
JP3400038B2 (ja) | 1993-10-19 | 2003-04-28 | 塩野義製薬株式会社 | ピリミジン誘導体の製造方法 |
GB9626746D0 (en) | 1996-12-23 | 1997-02-12 | Knoll Ag | Process |
GB9812413D0 (en) | 1998-06-10 | 1998-08-05 | Glaxo Group Ltd | Compound and its use |
TW550263B (en) | 1998-09-01 | 2003-09-01 | Nissan Chemical Ind Ltd | Method for reducing an organic solvent remaining in tris-(2,3-epoxypropyl)-isocyanurate crystals |
SI20070A (sl) | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Nove soli inhibitorjev HMG-CoA reduktaze |
GB9900339D0 (en) | 1999-01-09 | 1999-02-24 | Zeneca Ltd | Chemical compounds |
GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
US6777552B2 (en) | 2001-08-16 | 2004-08-17 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing calcium salt forms of statins |
GB0028429D0 (en) | 2000-11-22 | 2001-01-10 | Astrazeneca Ab | Therapy |
AU2002328835A1 (en) | 2001-07-06 | 2003-01-21 | Teva Pharmaceutical Industries Ltd | Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation |
CA2450820C (en) | 2001-08-16 | 2011-03-15 | Teva Pharmaceutical Industries Ltd. | Processes for preparing calcium salt forms of statins |
SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Astrazeneca Ab | Rosuvastatin in pre demented states |
KR100511533B1 (ko) * | 2002-04-09 | 2005-08-31 | 임광민 | 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법 |
BR0311195A (pt) | 2002-05-21 | 2005-02-22 | Ranbaxy Lab Ltd | Processo de preparação de rosuvastatina |
GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
US7566782B2 (en) | 2002-12-10 | 2009-07-28 | Ranbaxy Laboratories Limited | Process for the preparation of rosuvastatin |
GB0312896D0 (en) | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
WO2005021511A1 (en) | 2003-08-27 | 2005-03-10 | Hetero Drugs Limited | A novel process for amorphous rosuvastatin calcium |
EP1562912A2 (en) | 2003-08-28 | 2005-08-17 | Teva Pharmaceutical Industries Limited | Process for preparation of rosuvastatin calcium |
CA2546701C (en) | 2003-11-24 | 2010-07-27 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
WO2005054207A1 (en) | 2003-12-04 | 2005-06-16 | Glenmark Pharmaceuticals Limited | Process for the preparation of pyrimidine derivatives |
US20050159615A1 (en) | 2003-12-24 | 2005-07-21 | Entire Interest. | Process for preparation of statins with high syn to anti ratio |
WO2006035277A2 (en) | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium |
CN1807417A (zh) | 2005-01-18 | 2006-07-26 | 何如钧 | 新型无水无结晶型态的罗伐他汀钙盐 |
WO2006079611A1 (en) | 2005-01-31 | 2006-08-03 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of rosuvastatin calcium salt |
US20070037979A1 (en) * | 2005-02-22 | 2007-02-15 | Valerie Niddam-Hildesheim | Preparation of rosuvastatin |
US20070167625A1 (en) | 2005-02-22 | 2007-07-19 | Anna Balanov | Preparation of rosuvastatin |
US20090124803A1 (en) | 2005-03-22 | 2009-05-14 | Pandurang Balwant Deshpande | Process for preparation of rosuvastatin |
WO2006106526A1 (en) | 2005-04-04 | 2006-10-12 | Unichem Laboratories Limited | Process for preparation of calcium salt of rosuvastatin |
CN1872841A (zh) | 2005-06-01 | 2006-12-06 | 信谊药厂 | 瑞舒伐他汀钙及其关键中间体的制备方法 |
US9150518B2 (en) | 2005-06-24 | 2015-10-06 | Lek Pharmaceuticals, D.D. | Process for preparing amorphous rosuvastatin calcium of impurities |
ES2564807T5 (es) | 2005-06-24 | 2019-02-26 | Lek Pharmaceuticals | Proceso para preparación de rosuvastatina de calcio amorfa pura |
GB0514078D0 (en) | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
CN100352821C (zh) | 2005-08-22 | 2007-12-05 | 鲁南制药集团股份有限公司 | 一种瑞舒伐他汀钙中间体的制备方法 |
-
2006
- 2006-08-16 WO PCT/US2006/032539 patent/WO2007022488A2/en active Application Filing
- 2006-08-16 TW TW095130084A patent/TW200800917A/zh unknown
- 2006-08-16 CA CA2619576A patent/CA2619576C/en not_active Expired - Fee Related
- 2006-08-16 BR BRPI0605917-1A patent/BRPI0605917A2/pt not_active IP Right Cessation
- 2006-08-16 US US11/506,030 patent/US7868169B2/en not_active Expired - Fee Related
- 2006-08-16 JP JP2007535928A patent/JP2008515931A/ja active Pending
- 2006-08-16 EP EP06801964A patent/EP1805148A2/en not_active Ceased
- 2006-08-16 KR KR1020077008332A patent/KR20070062996A/ko not_active Application Discontinuation
- 2006-08-16 MX MX2007004427A patent/MX2007004427A/es not_active Application Discontinuation
-
2007
- 2007-09-24 IL IL186221A patent/IL186221A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW200800917A (en) | 2008-01-01 |
WO2007022488A3 (en) | 2007-05-03 |
EP1805148A2 (en) | 2007-07-11 |
IL186221A0 (en) | 2008-01-20 |
IL186221A (en) | 2011-11-30 |
WO2007022488A2 (en) | 2007-02-22 |
US20070123550A1 (en) | 2007-05-31 |
CA2619576A1 (en) | 2007-02-22 |
CA2619576C (en) | 2011-12-06 |
JP2008515931A (ja) | 2008-05-15 |
US7868169B2 (en) | 2011-01-11 |
BRPI0605917A2 (pt) | 2009-05-26 |
KR20070062996A (ko) | 2007-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
MX2010002836A (es) | Bortezomib y proceso para la produccion del mismo. | |
IN2012DN02610A (es) | ||
IN2014CN03629A (es) | ||
EP1880546A4 (en) | STRATEGIES FOR THE DISTRIBUTION OF MULTIMEDIA EVENTS BANDWIDTH CONSUMERS | |
IL183528A0 (en) | Process for preparing rosuvastatin | |
AU308588S (en) | Wristwatch | |
GB0410118D0 (en) | Novel bioreactor | |
PL1716099T3 (pl) | Haloalkilokarboksamidy do zwalczania mikroorganizmów | |
TW200619205A (en) | A method for preparing irbesartan and intermediates thereof | |
TW200637832A (en) | Process for preparing amorphous valsartan | |
MX2007004427A (es) | Intermedio de rosuvastatina cristalina. | |
GB0420881D0 (en) | Bioreactor | |
WO2007005967A3 (en) | Process for preparing valsartan | |
EP1877202A4 (en) | MULTI-STAGE COMPOSTING | |
AU2005100106A4 (en) | T&L ezyfume | |
AU2004904437A0 (en) | Work scheduling | |
AU2004100504A4 (en) | Waste Not | |
TW200745060A (en) | Novel process | |
AU2004904245A0 (en) | Fastener | |
AU2005900915A0 (en) | Circumference wristwatch | |
AU2005904859A0 (en) | Splint | |
AU2004901935A0 (en) | Clasp | |
AU303336S (en) | Oval plate | |
AU2004907130A0 (en) | Bioreactor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |